| Bioactivity | hMAO-B-IN-6 (compound 17d) is a potent and selective inhibitor of hMAO-B with an IC50 of 67.02 nM. hMAO-B-IN-6 significantly improves Scopolamine (HY-N0296)-induced cognitive impairment in AD mice[1]. |
| Name | hMAO-B-IN-6 |
| CAS | 2764830-43-3 |
| Formula | C19H20N2O5 |
| Molar Mass | 356.37 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Zhang C, et al. Chromone-based monoamine oxidase B inhibitor with potential iron-chelating activity for the treatment of Alzheimer's disease. J Enzyme Inhib Med Chem. 2023 Dec;38(1):100-117. |
hMAO-B-IN-6
CAS: 2764830-43-3 F: C19H20N2O5 W: 356.37
hMAO-B-IN-6 (compound 17d) is a potent and selective inhibitor of hMAO-B with an IC50 of 67.02 nM. hMAO-B-IN-6 significa
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.